Literature DB >> 24453717

Monitoring my multiple sclerosis: a patient-administered health-assessment scale.

Elsie E Gulick1, Marie Namey1, June Halper1.   

Abstract

Optimal health of people with multiple sclerosis (MS) can be promoted by patients' sharing of health information gained through periodic self-monitoring with their health-care providers. The purpose of this study was to develop a valid and reliable self-administered scale to obtain information about MS patients' health status and the impact of the disease on their daily lives. We named this scale "Monitoring My Multiple Sclerosis" (MMMS). A cross-sectional survey was conducted of 171 MS patients who completed the MMMS and Patient-Determined Disease Steps (PDDS) scales and provided information on their MS disease classification and demographic characteristics. Data analysis included several parametric procedures. Factor analysis of the 26-item MMMS resulted in four factors with satisfactory α reliability coefficients for the total scale (0.90) and factored subscales: Physical (0.85), Relationships (0.80), Energy (0.70), and Cognitive/Mental (0.67). Analysis of variance demonstrated that the total scale and the Physical subscale, but not the Relationships subscale, showed significantly worse functioning for patients with either moderate or severe disability as measured by the PDDS than for patients with mild disability (P < .001). The Cognitive/Mental subscale showed significantly worse functioning for patients with moderate disability than for patients with mild disability (P < .05). However, the Energy subscale showed significantly worse functioning among moderately disabled patients than among severely disabled patients (P < .01). Independent t tests demonstrated that patients classified as having secondary progressive multiple sclerosis had significantly worse scores on the total MMMS (P < .05) and the Physical subscale (P < .001) than those classified as having relapsing-remitting multiple sclerosis. The MMMS demonstrated satisfactory reliability and validity and is recommended for use by MS patients and their health-care providers as a mechanism to promote the sharing of health information, to the benefit of both patients and providers.

Entities:  

Year:  2011        PMID: 24453717      PMCID: PMC3882968          DOI: 10.7224/1537-2073-13.3.137

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  42 in total

1.  Daily negative interactions and mood among patients and partners dealing with multiple sclerosis (MS): the moderating effects of emotional support.

Authors:  Annet M Kleiboer; Roeline G Kuijer; Joop J Hox; Peter J H Jongen; Stephan T F M Frequin; Jozien M Bensing
Journal:  Soc Sci Med       Date:  2006-09-29       Impact factor: 4.634

2.  Evaluating storage, retention, and retrieval in disordered memory and learning.

Authors:  H Buschke; P A Fuld
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

3.  Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning.

Authors:  P A Arnett; C I Higginson; W D Voss; B Wright; W I Bender; J M Wurst; J M Tippin
Journal:  Neuropsychology       Date:  1999-07       Impact factor: 3.295

4.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

5.  High concurrent presence of disability in multiple sclerosis. Associations with perceived health.

Authors:  Sverker Johansson; Charlotte Ytterberg; Ingrid M Claesson; Jenny Lindberg; Jan Hillert; Magnus Andersson; Lotta Widén Holmqvist; Lena von Koch
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

6.  A health-related quality of life measure for multiple sclerosis.

Authors:  B G Vickrey; R D Hays; R Harooni; L W Myers; G W Ellison
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

Review 7.  Effective multiple sclerosis management through improved patient assessment.

Authors:  Amy Perrin Ross; Natalie Hackbarth; Christine Rohl; Kristi Whitmyre
Journal:  J Neurosci Nurs       Date:  2008-06       Impact factor: 1.230

8.  Prevalence of sleep problems in individuals with multiple sclerosis.

Authors:  A M Bamer; K L Johnson; D Amtmann; G H Kraft
Journal:  Mult Scler       Date:  2008-07-16       Impact factor: 6.312

9.  Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis.

Authors:  N Figved; R Benedict; G Klevan; K M Myhr; H I Nyland; N I Landrø; J P Larsen; D Aarsland
Journal:  Mult Scler       Date:  2008-09       Impact factor: 6.312

Review 10.  Cognitive impairment in multiple sclerosis.

Authors:  Alexander Winkelmann; Claudia Engel; Annett Apel; Uwe K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

View more
  5 in total

1.  Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis database.

Authors:  Robert J Fox; Amber R Salter; Tuula Tyry; Jennifer Sun; Xiaojun You; Genevieve Laforet; Denise Campagnolo
Journal:  Int J MS Care       Date:  2013

2.  Telemedicine for Monitoring MS Activity and Progression.

Authors:  Nuria Sola-Valls; Yolanda Blanco; Maria Sepúlveda; Eugenia Martinez-Hernandez; Albert Saiz
Journal:  Curr Treat Options Neurol       Date:  2015-11       Impact factor: 3.598

3.  Validity and Reliability of the Turkish Version of the Monitoring My Multiple Sclerosis Scale.

Authors:  Cansu Polat; Zeliha Tülek; Murat Kürtüncü; Mefkure Eraksoy
Journal:  Noro Psikiyatr Ars       Date:  2017-01-19       Impact factor: 1.339

4.  Validity and Reliability of the Turkish Version of the Multiple Sclerosis-Related Symptom Checklist.

Authors:  Zeliha Tülek; Cansu Polat; Murat Kürtüncü; Mefkure Eraksoy
Journal:  Noro Psikiyatr Ars       Date:  2016-04-26       Impact factor: 1.339

5.  Insomnia among non-depressed multiple sclerosis patients: a cross-sectional study.

Authors:  A A Alhazzani; A Alshahrani; M Alqahtani; R Alamri; R Alqahtani; M Alqahtani; M Alahmarii
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2018-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.